Home/Filings/4/A/0000895345-23-000573

4/A//SEC Filing

LEWIS JOSEPH 4/A

Accession 0000895345-23-000573

CIK 0001819133other

View on SEC.gov Company Profile

Filed

Oct 10, 8:00 PM ET

Accepted

Oct 11, 7:22 PM ET

Size

18.2 KB

Accession

0000895345-23-000573

Insider Transaction Report

Form 4/AAmended

Period: 2023-08-11

Tango Therapeutics, Inc.TNGX

Davis Aaron I.

DirectorChief Executive Officer

Transactions

Award
Common Stock
2023-08-11$5.15/sh+475,000$2,446,250→ 743,542 total(indirect: See footnote)
Award
Prefunded Warrant
2023-08-11$5.15/sh+2,340,579$12,053,748→ 2,340,579 total
→ Common Stock (2,340,579 underlying)

Holdings

Common Stock
7,123,642
Common Stock
(indirect: See footnote)
5,000
Common Stock
(indirect: See footnote)
26,961
Common Stock
(indirect: See footnote)
6,988,450

Boxer Asset Management Inc.

10% Owner

Transactions

Award
Prefunded Warrant
2023-08-11$5.15/sh+2,340,579$12,053,748→ 2,340,579 total
→ Common Stock (2,340,579 underlying)
Award
Common Stock
2023-08-11$5.15/sh+475,000$2,446,250→ 743,542 total(indirect: See footnote)

Holdings

Common Stock
(indirect: See footnote)
6,988,450
Common Stock
7,123,642
Common Stock
(indirect: See footnote)
26,961
Common Stock
(indirect: See footnote)
5,000

Boxer Capital, LLC

10% Owner

Transactions

Award
Common Stock
2023-08-11$5.15/sh+475,000$2,446,250→ 743,542 total(indirect: See footnote)
Award
Prefunded Warrant
2023-08-11$5.15/sh+2,340,579$12,053,748→ 2,340,579 total
→ Common Stock (2,340,579 underlying)

Holdings

Common Stock
(indirect: See footnote)
5,000
Common Stock
7,123,642
Common Stock
(indirect: See footnote)
26,961
Common Stock
(indirect: See footnote)
6,988,450

MVA Investors, LLC

10% Owner

Transactions

Award
Prefunded Warrant
2023-08-11$5.15/sh+2,340,579$12,053,748→ 2,340,579 total
→ Common Stock (2,340,579 underlying)
Award
Common Stock
2023-08-11$5.15/sh+475,000$2,446,250→ 743,542 total(indirect: See footnote)

Holdings

Common Stock
(indirect: See footnote)
5,000
Common Stock
7,123,642
Common Stock
(indirect: See footnote)
26,961
Common Stock
(indirect: See footnote)
6,988,450

LEWIS JOSEPH

10% Owner

Transactions

Award
Common Stock
2023-08-11$5.15/sh+475,000$2,446,250→ 743,542 total(indirect: See footnote)
Award
Prefunded Warrant
2023-08-11$5.15/sh+2,340,579$12,053,748→ 2,340,579 total
→ Common Stock (2,340,579 underlying)

Holdings

Common Stock
7,123,642
Common Stock
(indirect: See footnote)
5,000
Common Stock
(indirect: See footnote)
26,961
Common Stock
(indirect: See footnote)
6,988,450

Footnotes (6)

[F1]These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
[F2]These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
[F3]These securities are owned directly by Mr. Davis. Each reporting person other than Mr. Davis disclaims beneficial ownership of these securities.
[F4]These securities are owned directly by Braslyn Ltd. Mr. Lewis is the sole indirect owner of Braslyn Ltd. Each reporting person other than Mr. Lewis disclaims beneficial ownership of these securities.
[F5]These securities are owned directly by BCTG Holdings, LLC ("BCTG"). Boxer Capital is the majority member of BCTG and MVA Investors is a member of BCTG. Mr. Davis is an investment manager of BCTG. Each reporting person disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
[F6]The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer.

Documents

1 file

4
form4.xml

Issuer

Tango Therapeutics, Inc.

CIK 0001819133

→

Entity typeother

Related Parties

filerCIK 0001015747

Filing Metadata

Form type: 4/A
Filed: Oct 10, 8:00 PM ET
Accepted: Oct 11, 7:22 PM ET
Size: 18.2 KB

View on SEC.gov